Patents by Inventor Olivia Osborn

Olivia Osborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHLORIDE INTRACELLULAR CHANNEL 1 FOR REGULATION OF FOOD INTAKE
    Publication number: 20220313636
    Abstract: Compositions and methods of use for modulating weight gain in a subject. Methods for treating obesity in a subject comprising administering to a subject in need an effective amount of a chloride intracellular channel protein 1 (Clic1) inhibitor, such as indanyloxyacetic acid 94 (IAA94).
    Type: Application
    Filed: May 6, 2020
    Publication date: October 6, 2022
    Inventors: Olivia Osborn, Rizaldy Zapata
  • EDN3-LIKE PEPTIDES AND USES THEREOF
    Publication number: 20130345392
    Abstract: This application discloses novel EDN3-like polypeptides. One such short polypeptide is EDN3 97-140, which is a 44 amino acid peptide that stimulates GLP-1 secretion in enteric cells and inhibits gluconeogenesis in hepatic cells. EDN3 97-140, as well as other EDN3-like polypeptides provided herein may be used in the study and treatment of a number of indications, including the treatment of metabolic disorders such as obesity and diabetes.
    Type: Application
    Filed: March 1, 2012
    Publication date: December 26, 2013
    Applicant: Pfizer Inc
    Inventors: Tamas Bartfai, Bruno Conti, Avijit Ghosh, John Hadcock, Olivia Osborn, Manuel Sanchez-Alavez, Jean Schaefer, Iustin Tabarean